Immunome, Inc. (IMNM)
$19.55+1.24%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.9B
- Beta
- 2.13
- P/E (TTM)
- -7.60
- Short % float
- 21.15%
- Days to cover
- 9.9
- SI change
- +3.2%
- 1W
- -6.46%
- 1M
- -21.71%
- vs SPY 1W
- -7.62%
- vs SPY 1M
- -24.70%
Industry peers
FMP comparable companies · ranked by market cap
- SYRESELLSpyre Therapeutics, Inc.$8.1BCRISISQ 10$93.19+7.25%
- ABCLBUYAbCellera Biologics Inc.$4.2BCRISISQ -6$13.74+4.41%
- VERASELLVera Therapeutics, Inc.$2.2BCRISISQ 21$30.42+0.50%
- PHVSSELLPharvaris N.V.$2.2BCRISISQ 15$31.19-0.06%
- CLDXSELLCelldex Therapeutics, Inc.$2.1BCRISISQ 5$31.65+2.01%
- BHVNSELLBiohaven Ltd.$1.9BCRISISQ 17$12.87+1.26%
- ZBIOSELLZenas BioPharma, Inc.$1.8BCRISISQ 15$28.30+3.89%
- NTLABUYIntellia Therapeutics, Inc.$1.7BRECOVERYQ 4$12.26+3.73%
- MAZEBUYMaze Therapeutics, Inc.$1.5BRECOVERYQ 36$26.43+4.75%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
